Abstract

22
Short peptides in food protein hydrolysates are of significant interest as they may be 23 highly bioactive whilst also being bioavailable. A dipeptidyl peptidase IV (DPP-IV) 24 inhibitory whey protein hydrolysate (WPH) was fractionated using nanofiltration (NF) with a 25
200 Da MWCO membrane. The DPP-IV half maximal inhibitory concentration of the NF 26 permeate (IC 50 = 0.66 ± 0.08 mg protein equivalent mL -1 ) was significantly more potent (P > 27 0.05) than that of the starting WPH (IC 50 = 0.94 ± 0.24 mg protein equivalent mL -1 ) and 28 associated retentate (IC 50 = 0.82 ± 0.13 mg protein equivalent mL -1 ). This confirmed the 29 contribution of short peptides within the NF permeate to the overall DPP-IV inhibitory 30
activity. An hydrophilic interaction liquid chromatography (HILIC-) and reverse-phase (RP-) 31 liquid chromatography tandem mass spectrometry (LC-MS/MS) strategy, based on two 32 retention time models, allowed detection of eight free amino acids and eight di-to 33 tetrapeptides in the NF permeate. The potential sequences of the peptides within the NF 34 permeate were then ranked on the basis of their highest probability of occurrence. 35
Introduction
45
There is a growing interest in the utilisation of naturally-derived food products with 46 health benefits such as antioxidant, antidiabetic and antihypertensive properties (Korhonen & 47 Sibilia, Caroli, & Cocchi, 2011). However, to our knowledge, di-and tripeptides with DPP-95 IV inhibitory properties have to date not been identified within milk protein hydrolysates by 96
LC-MS. 97
This study was assessed using a whey protein hydrolysate (WPH) with DPP-IV 98 inhibitory activity. NF of the WPH was used to enrich for short peptides in the permeate. 99
Furthermore, milk derived short peptides could be detected and their overall contribution to 100 DPP-IV inhibitory properties was assessed using a confirmatory study. 
Enzymatic hydrolysis of whey proteins and NF fractionation of the hydrolysate 122
The WPH was generated using a food-grade pancreatic proteinase preparation at 123 semi-pilot scale (200 L) as described by Nongonierma and FitzGerald (2013b 
DPP-IV inhibition assay 142
The protein hydrolysates were dispersed in HPLC-grade water at concentrations 143 ranging from 31.3 × 10 -3 to 5.0 mg mL -1 (final concentration). The DPP-IV inhibition assay 144 was carried out as described by Nongonierma and FitzGerald (2013a Retention time prediction models were coupled to MS/MS data in order to improve 182 peptide identification. The HILIC retention time model used was as described by Le Maux et 183 al. (2015) . Another model based on RP separation was developed herein using a similar 184 strategy. Briefly, a training set of 153 standard peptides was used to determine the algorithm 185 of the RP prediction model. These peptides were selected based on their range of 186 hydrophilicity/hydrophobicity, peptide size (di-to tetrapeptides) and sequence. Matlab 187 (version 2014b, The MathWorks Inc., Natick, MA, USA) was used to generate coefficients 188 representing the impact of each amino acid on peptide apparent hydrophobicity. These 189 hydrophobicity coefficients were determined depending on amino acid location (C-, Ndetermined as the sum of each amino acid coefficient in the peptide chain (Meek, 1980 The approach to identify short peptides within the nanofiltrate was also as described 196
by Le Maux et al. (2015) . A list of potential peptides, which corresponded to the properties of 197 the detected peptides, was generated using a mass tolerance set at 0.1 Da. An in-house bovine 198 milk protein database was built in order to discard non relevant peptides using all the 199 available genetic variants, given in PubMed, of the major bovine milk proteins (β-200 lactoglobulin, α-lactalbumin, bovine serum albumin, lactoferrin, α s1 -, α s2 -, β-and κ-casein). 
Results
Peptide profile of the WPH and associated NF fractions 215
The RP-UPLC profiles for the WPH and its associated NF retentate and permeate are 216 depicted in Fig. 1 . The WPH and its NF retentate had similar peptide profiles showing a large 217 number of peptide peaks eluting during the first 25 min of the MeCN gradient. In contrast, 218 the NF permeate shows a less complex profile, with 3 main peaks eluting at 2.9, 4.8 and 7.7 219 min. Similar peaks were also present in the WPH and the NF retentate, but at a lower 220 intensity in the WPH than in the NF permeate. 221 222
DPP-IV inhibitory activity of the WPH and associated NF fractions 223
The DPP-IV IC 50 values were 0.94 ± 0.24, 0.82 ± 0.13 and 0.66 ± 0.08 mg protein 224 equivalent mL -1 for the WPH, NF retentate and permeate, respectively ( Table 1 ). The DPP-IV 225 IC 50 for the NF permeate was significantly lower (P < 0.05) than that of the WPH and NF 226 retentate. 227
The NF permeate peptide profile showed a significantly reduced complexity (i.e., 228 three main peptide peaks, Fig. 1 ). In addition, it displayed the highest DPP-IV inhibitory 229 potency (Table 1) . Therefore, LC-MS/MS analysis was applied to the NF permeate with a 230 view to specifically identify short peptides contributing to the overall DPP-IV inhibitory 231
properties of the WPH. 232 233
Development of the reverse phase (RP) retention time prediction (RTpred) model 234
The retention time prediction (RT pred ) model was best described by the equation: 235
The constants a and b were optimised through iterations of the amino acid 237 hydrophobic coefficients and were defined in the operating conditions as -1.384 ± 0.194 and 238 0.9383 ± 0.006, respectively. The established amino acid hydrophobic coefficients that 239 allowed equation 1 to have the highest R 2 are described in Supplementary Table S1 . The 240 peptide apparent hydrophobicity (H) was calculated using these coefficients. Tryptophan (W) 241 had the highest hydrophobic coefficient, followed by phenylalanine ( (Table 2) . For the first time, the peptides of this NF permeate sample were 270 subsequently identified. These compounds were analysed by correlating their molecular 271 mass, retention time and MS/MS spectrum. As several sequences could match the properties 272 of one compound, these sequences were defined as potential peptides within the NF 273 permeate. The presence of potential peptide sequences was searched against an in-house 274 bovine milk protein database in order to reject non-relevant peptides. Eight amino acids, 275 seven dipeptides and one tetrapeptide were detected within the NF permeate. The potential 276 peptide sequences were ranked based on their highest probability of occurrence (Table 2) . 277
This was achieved by using the two retention time models (RP and HILIC) to allow for a 278 more accurate ranking of homologous peptides. For instance, the molecular mass of peptide 279
No. 10 in Table 2 corresponded to 6 (GI, GL, IG, LG, AV and VA) potential peptide 280 sequences, but only 5 (GI, GL, IG, LG and AV) of these had predicted retention times that 281 were within 10 min of the observed peptide retention time. Moreover, these potential peptides 282
were ranked based on their retention time differences (predicted versus observed retention 283 times), with GI and GL having the highest probability, followed by IG and LG, and then AV. (Table 2) . Therefore, only the peptide sequences which had 293 not previously been reported for their DPP-IV inhibitory properties were synthesised for 294 further confirmatory study. It was conducted to determine which compounds within the NF 295 permeate were bioactive. Previously published DPP-IV IC 50 values for the amino acids found 296 within the NF permeate are shown in Table 3 inhibitory properties in this study (Table 2) . Their DPP-IV IC 50 values are reported in Table  302 3. WL was the most potent for DPP-IV inhibitory peptide identified within the NF permeate, The interest in focusing on short (di-tri and tetra-) peptides was related to the fact that 374 these sequences may be bioavailable as they may be able to survive gastrointestinal digestion 375 and also display an increased intestinal permeability compared to larger peptides or free 376 amino acids. 
Conclusion
387
A new strategy to identify short peptides was developed, being innovative in the 389 utilisation of a RP and HILIC approach designed for di-to tetrapeptides. This new approach 390 allowed the differentiation between homologous peptides. This method was optimised to 391 identify short peptides which cannot usually be identified by MS/MS and de novo searches. 392
The use of further separation methods prior to MS, such as ion-exchange or capillary 393 electrophoresis, may lead to the determination of a unique peptide sequence for each 394 compound detected. 395
To our knowledge, NF has not been previously employed for the fractionation and 396 further identification of DPP-IV inhibitory peptides. Specific short peptide sequences found 397 within the NF permeate of the WPH were shown to be relatively potent DPP-IV inhibitory 398 peptides (IC 50 < 170 µM). This demonstrated that short peptides were also responsible for the 399 overall DPP-IV inhibitory potential of the WPH. Furthermore, these peptides were predicted 400 in silico to be relatively stable to gastrointestinal digestion. However, these results would 401 need to be confirmed following in vitro and in vivo digestion of the fraction. 402
The results reported in this study demonstrated that, with the strategy employed, it 403 was possible to improve the fractionation and subsequently the detection of short DPP-IV 404 inhibitory peptides in a milk protein hydrolysate. The strategy described herein is highly 405 relevant to the discovery of short bioactive peptide sequences. * Sequences separated by a comma have the same probability of occurrence, whereas ">" showed the sequences with higher probability of occurrence. Novel peptides selected for the DPP-IV inhibitory confirmatory study are highlighted in bold. ** Peptides previously identified for their DPP-IV inhibitory properties as described elsewhere (Lan et al., 2015; Nongonierma & FitzGerald, 2014 Table S1 . Hydrophobic coefficients of amino acid residues determined when the amino is present at the N-, C-terminus and within a peptide sequence. IV  PEPS  IV  PEPS2  IV  TRYPS  IV  ELASTASE  IV  CH-HI  IV  CH-LO  IV  VI  PEPS  VI  PEPS2  VI  TRYPS  VI  ELASTASE  VI  CH-HI  VI  CH-LO  VI  LV  PEPS  LV  PEPS2  LV  TRYPS  LV  ELASTASE  LV  CH-HI  LV  CH-LO  L, V  IY  PEPS  IY  PEPS2  IY  TRYPS  IY  ELASTASE  IY  CH-HI  IY CH-LO  IY  LY  PEPS  LY  PEPS2  LY  TRYPS  LY  ELASTASE  LY  CH-HI  LY  CH-LO L, Y *Free amino acids and peptides predicted to be released by in silico digestion of the peptides within the nanofiltration (NF) permeate of the whey protein hydrolysate (WPH) using pepsin pH 1.3 (PEPS) and pH > 2.0 (PEPS2), pancreatic elastase (ELAS), trypsin (TRYPS), chymotrypsin high (CH-HI) and low (CH-LO) specificity. 5 6 7 8 9
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